2024-04-012025-03-312025-03-31false13307312RSD Medical Limited2025-09-08falseiso4217:GBPxbrli:pure133073122024-03-31133073122025-03-31133073122024-04-012025-03-31133073122023-03-31133073122024-03-31133073122023-04-012024-03-3113307312bus:SmallEntities2024-04-012025-03-3113307312bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3113307312bus:AbridgedAccounts2024-04-012025-03-3113307312bus:PrivateLimitedCompanyLtd2024-04-012025-03-3113307312core:WithinOneYear2025-03-3113307312core:AfterOneYear2025-03-3113307312core:WithinOneYear2024-03-3113307312core:AfterOneYear2024-03-3113307312core:ShareCapital2025-03-3113307312core:SharePremium2025-03-3113307312core:RevaluationReserve2025-03-3113307312core:OtherReservesSubtotal2025-03-3113307312core:RetainedEarningsAccumulatedLosses2025-03-3113307312core:ShareCapital2024-03-3113307312core:SharePremium2024-03-3113307312core:RevaluationReserve2024-03-3113307312core:OtherReservesSubtotal2024-03-3113307312core:RetainedEarningsAccumulatedLosses2024-03-3113307312core:LandBuildings2025-03-3113307312core:PlantMachinery2025-03-3113307312core:Vehicles2025-03-3113307312core:FurnitureFittings2025-03-3113307312core:OfficeEquipment2025-03-3113307312core:NetGoodwill2025-03-3113307312core:IntangibleAssetsOtherThanGoodwill2025-03-3113307312core:ListedExchangeTraded2025-03-3113307312core:UnlistedNon-exchangeTraded2025-03-3113307312core:LandBuildings2024-03-3113307312core:PlantMachinery2024-03-3113307312core:Vehicles2024-03-3113307312core:FurnitureFittings2024-03-3113307312core:OfficeEquipment2024-03-3113307312core:NetGoodwill2024-03-3113307312core:IntangibleAssetsOtherThanGoodwill2024-03-3113307312core:ListedExchangeTraded2024-03-3113307312core:UnlistedNon-exchangeTraded2024-03-3113307312core:LandBuildings2024-04-012025-03-3113307312core:PlantMachinery2024-04-012025-03-3113307312core:Vehicles2024-04-012025-03-3113307312core:FurnitureFittings2024-04-012025-03-3113307312core:OfficeEquipment2024-04-012025-03-3113307312core:NetGoodwill2024-04-012025-03-3113307312core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3113307312core:ListedExchangeTraded2024-04-012025-03-3113307312core:UnlistedNon-exchangeTraded2024-04-012025-03-3113307312core:MoreThanFiveYears2024-04-012025-03-3113307312core:Non-currentFinancialInstruments2025-03-3113307312core:Non-currentFinancialInstruments2024-03-3113307312dpl:CostSales2024-04-012025-03-3113307312dpl:DistributionCosts2024-04-012025-03-3113307312core:LandBuildings2024-04-012025-03-3113307312core:PlantMachinery2024-04-012025-03-3113307312core:Vehicles2024-04-012025-03-3113307312core:FurnitureFittings2024-04-012025-03-3113307312core:OfficeEquipment2024-04-012025-03-3113307312dpl:AdministrativeExpenses2024-04-012025-03-3113307312core:NetGoodwill2024-04-012025-03-3113307312core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3113307312dpl:GroupUndertakings2024-04-012025-03-3113307312dpl:ParticipatingInterests2024-04-012025-03-3113307312dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3113307312core:ListedExchangeTraded2024-04-012025-03-3113307312dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3113307312core:UnlistedNon-exchangeTraded2024-04-012025-03-3113307312dpl:CostSales2023-04-012024-03-3113307312dpl:DistributionCosts2023-04-012024-03-3113307312core:LandBuildings2023-04-012024-03-3113307312core:PlantMachinery2023-04-012024-03-3113307312core:Vehicles2023-04-012024-03-3113307312core:FurnitureFittings2023-04-012024-03-3113307312core:OfficeEquipment2023-04-012024-03-3113307312dpl:AdministrativeExpenses2023-04-012024-03-3113307312core:NetGoodwill2023-04-012024-03-3113307312core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3113307312dpl:GroupUndertakings2023-04-012024-03-3113307312dpl:ParticipatingInterests2023-04-012024-03-3113307312dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3113307312core:ListedExchangeTraded2023-04-012024-03-3113307312dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3113307312core:UnlistedNon-exchangeTraded2023-04-012024-03-3113307312core:NetGoodwill2025-03-3113307312core:IntangibleAssetsOtherThanGoodwill2025-03-3113307312core:LandBuildings2025-03-3113307312core:PlantMachinery2025-03-3113307312core:Vehicles2025-03-3113307312core:FurnitureFittings2025-03-3113307312core:OfficeEquipment2025-03-3113307312core:AfterOneYear2025-03-3113307312core:WithinOneYear2025-03-3113307312core:ListedExchangeTraded2025-03-3113307312core:UnlistedNon-exchangeTraded2025-03-3113307312core:ShareCapital2025-03-3113307312core:SharePremium2025-03-3113307312core:RevaluationReserve2025-03-3113307312core:OtherReservesSubtotal2025-03-3113307312core:RetainedEarningsAccumulatedLosses2025-03-3113307312core:NetGoodwill2024-03-3113307312core:IntangibleAssetsOtherThanGoodwill2024-03-3113307312core:LandBuildings2024-03-3113307312core:PlantMachinery2024-03-3113307312core:Vehicles2024-03-3113307312core:FurnitureFittings2024-03-3113307312core:OfficeEquipment2024-03-3113307312core:AfterOneYear2024-03-3113307312core:WithinOneYear2024-03-3113307312core:ListedExchangeTraded2024-03-3113307312core:UnlistedNon-exchangeTraded2024-03-3113307312core:ShareCapital2024-03-3113307312core:SharePremium2024-03-3113307312core:RevaluationReserve2024-03-3113307312core:OtherReservesSubtotal2024-03-3113307312core:RetainedEarningsAccumulatedLosses2024-03-3113307312core:NetGoodwill2023-03-3113307312core:IntangibleAssetsOtherThanGoodwill2023-03-3113307312core:LandBuildings2023-03-3113307312core:PlantMachinery2023-03-3113307312core:Vehicles2023-03-3113307312core:FurnitureFittings2023-03-3113307312core:OfficeEquipment2023-03-3113307312core:AfterOneYear2023-03-3113307312core:WithinOneYear2023-03-3113307312core:ListedExchangeTraded2023-03-3113307312core:UnlistedNon-exchangeTraded2023-03-3113307312core:ShareCapital2023-03-3113307312core:SharePremium2023-03-3113307312core:RevaluationReserve2023-03-3113307312core:OtherReservesSubtotal2023-03-3113307312core:RetainedEarningsAccumulatedLosses2023-03-3113307312core:AfterOneYear2024-04-012025-03-3113307312core:WithinOneYear2024-04-012025-03-3113307312core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3113307312core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3113307312core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3113307312core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3113307312core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3113307312core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3113307312core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3113307312core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3113307312core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3113307312core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3113307312core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3113307312core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3113307312core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3113307312core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3113307312core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3113307312core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3113307312core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3113307312core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3113307312core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3113307312core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3113307312core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3113307312core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3113307312core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3113307312core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3113307312core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3113307312core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3113307312core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3113307312bus:Director12024-04-012025-03-31133073121bus:Director12024-03-31133073121bus:Director12024-04-012025-03-31133073121bus:Director12025-03-31133073122024-03-31133073122024-04-012025-03-31133073122025-03-31

RSD Medical Limited

Registered Number
13307312
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

RSD Medical Limited
Company Information
for the year from 1 April 2024 to 31 March 2025

Director

Rhodri Sion David

Company Secretary

Eleanor Elizabeth David

Registered Address

2 Dukes Court
Bognor Road
Chichester
PO19 8FX

Registered Number

13307312 (England and Wales)
RSD Medical Limited
Balance Sheet as at
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets3534191
534191
Current assets
Debtors9,5565,550
Cash at bank and on hand33,2135,150
42,76910,700
Creditors amounts falling due within one year(12,060)(9,792)
Net current assets (liabilities)30,709908
Total assets less current liabilities31,2431,099
Provisions for liabilities(134)(36)
Net assets31,1091,063
Capital and reserves
Called up share capital1010
Profit and loss account31,0991,053
Shareholders' funds31,1091,063
The financial statements were approved and authorised for issue by the Director on 8 September 2025, and are signed on its behalf by:
Rhodri Sion David
Director
Registered Company No. 13307312
RSD Medical Limited
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the rendering of services.
Defined contribution pension plan
The company operates a defined contribution pension plan for the benefit of its employees. Contributions are recognised as expenses as they become payable. Differences between contributions payable in the year and those actually paid are recognised as either prepayments or accruals in the balance sheet. The assets of the defined contribution pension scheme are held separately from those of the company in an independently administered fund.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Straight line (years)
Office Equipment4
2.Average number of employees

20252024
Average number of employees during the year11
3.Tangible fixed assets

Total

£
Cost or valuation
At 01 April 24654
Additions623
At 31 March 251,277
Depreciation and impairment
At 01 April 24463
Charge for year280
At 31 March 25744
Net book value
At 31 March 25534
At 31 March 24191
4.Operating lease commitments
At 31 March 2025, the company had financial commitments totalling £14,820 (2024: Nil).
5.Directors advances, credits and guarantees

Brought forward

Amount advanced

Amount repaid

Carried forward

££££
Rhodri Sion David02,1229081,214
02,1229081,214